| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8424856 | Stem Cell Research | 2018 | 9 Pages |
Abstract
The presented method could help to study genetic risk variants, using the CRISPR/Cas technology through the introduction of Knockouts or Knockins of risk variants. Finally, this method can be applied for drug screening.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Anja Trillhaase, Undine Haferkamp, Alexandra Rangnau, Marlon Märtens, Beatrice Schmidt, Michaela Trilck, Philip Seibler, Redouane Aherrahrou, Jeanette Erdmann, Zouhair Aherrahrou,